NEVIRAPINE — all Canadian products
8 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NEVIRAPINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02396653 | APO-NEVIRAPINE | APOTEX INC | Tablet | Oral | NEVIRAPINE 200 MG | Approved | |
| 02318601 | AURO-NEVIRAPINE | AURO PHARMA INC | Tablet | Oral | NEVIRAPINE 200 MG | Marketed | |
| 02405776 | JAMP NEVIRAPINE | JAMP PHARMA CORPORATION | Tablet | Oral | NEVIRAPINE 200 MG | Marketed | |
| 02387727 | MYLAN-NEVIRAPINE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | NEVIRAPINE 200 MG | Marketed | |
| 02427931 | APO-NEVIRAPINE XR | APOTEX INC | Tablet (Extended-Release) | Oral | NEVIRAPINE 400 MG | Cancelled Post Market | |
| 02352893 | TEVA-NEVIRAPINE | TEVA CANADA LIMITED | Tablet | Oral | NEVIRAPINE 200 MG | Cancelled Post Market | |
| 02238748 | VIRAMUNE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | NEVIRAPINE 200 MG | Cancelled Post Market | |
| 02367289 | VIRAMUNE XR | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet (Extended-Release) | Oral | NEVIRAPINE 400 MG | Cancelled Post Market |
Browse other molecules: